Papillon Health is a leading innovator in the development and manufacturing of advanced intensive care beds, designed to enhance patient care and optimize the efficiency of medical personnel. Founded in 2020, our company has been committed to creating cutting-edge medical solutions that address the evolving needs of healthcare institutions. Our product line features four models, offering a comprehensive range of functionalities to meet diverse market demands across various price segments. Key innovations include the verticalizer for patient rehabilitation, anti-decubitus regimen to prevent pressure sores, and electric CPR for emergency situations, all integrated into a robust and adaptable design.
Operating in a global market valued at $5-6 billion with an annual growth rate of 7%, Papillon Health is strategically focused on expanding its presence in the United States and Latin America (LATAM), where there is a growing demand for high-quality medical equipment. We are dedicated to reducing the burden on healthcare professionals while improving patient outcomes, offering solutions that combine technological excellence with practical application.
We invite collaboration with investors seeking opportunities in a rapidly growing sector and distributors interested in enhancing their portfolios. Papillon Health is open to partnerships through an OEM (Original Equipment Manufacturer) model, enabling distributors to market our products under their own brands, tailored to local market requirements. For more information or to discuss potential cooperation, please contact us via private message.

ICU beds "Papillon"

Org chart

Teams

Offices

ICU beds "Papillon"

Org chart

Teams

Offices

Related companies